Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from ...

Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.

They were randomized to either titration of that dose up to 4.5 mg or switched to tirzepatide titrated up to 15 mg (or maximum tolerated doses of both). Most in both groups were also taking oral ...

Participants were randomly assigned either to escalation of dulaglutide to 4.5 mg or maximum tolerated dose (MTD), or to ...

Patients with poorly controlled type 2 diabetes despite being on dulaglutide had better outcomes if they switched to tirzepatide than if they upped their dulaglutide dose. In this randomized trial ...

The researchers found that at week 40, the change from baseline in HbA1c was −1.44 and −0.67% with tirzepatide and dulaglutide escalation to 4.5 mg or maximum tolerated dose, respectively.

Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese ...

The trial examined the effect of Eli Lilly’s glucagon-like peptide-1 receptor agonist (GLP-1RA) tirzepatide ... Patients were on a starting dose of 2.5mg/week, which was uptitrated by 2.5mg ...